Recro Pharma, Inc. 4
4 · Recro Pharma, Inc. · Filed Dec 19, 2014
Insider Transaction Report
Form 4
Mack Randall
Senior VP, Development
Transactions
- Award
Employee Stock Option (right to buy)
2014-12-17+19,000→ 19,000 totalExercise: $2.47Exp: 2024-12-17→ Common Stock (19,000 underlying) - Award
Employee Stock Option (right to buy)
2014-12-17+19,000→ 19,000 totalExercise: $2.47Exp: 2024-12-17→ Common Stock (19,000 underlying)
Footnotes (2)
- [F1]The option vests monthly in equal proportions over a period of four years beginning on December 17, 2014.
- [F2]The option vests 30% upon satisfaction of certain performance conditions, and then monthly thereafter in equal proportions over a three year period beginning on the date the performance conditions are satisfied.